Genetic diversity within diagnostic sputum samples is mirrored in the culture of Mycobacterium tuberculosis across different settings.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
05 Sep 2024
Historique:
received: 06 03 2024
accepted: 02 08 2024
medline: 6 9 2024
pubmed: 6 9 2024
entrez: 5 9 2024
Statut: epublish

Résumé

Culturing and genomic sequencing of Mycobacterium tuberculosis (MTB) from tuberculosis (TB) cases is the basis for many research and clinical applications. The alternative, culture-free sequencing from diagnostic samples, is promising but poses challenges to obtain and analyse the MTB genome. Paradoxically, culture is assumed to impose a diversity bottleneck, which, if true, would entail unexplored consequences. To unravel this paradox we generate high-quality genomes of sputum-culture pairs from two different settings after developing a workflow for sequencing from sputum and a tailored bioinformatics analysis. Careful downstream comparisons reveal sources of sputum-culture incongruences due to false positive/negative variation associated with factors like low input MTB DNA or variable genomic depths. After accounting for these factors, contrary to the bottleneck dogma, we identify a 97% variant agreement within sputum-culture pairs, with a high correlation also in the variants' frequency (0.98). The combined analysis from five different settings and more than 100 available samples shows that our results can be extrapolated to different TB epidemic scenarios, demonstrating that for the cases tested culture accurately mirrors clinical samples.

Identifiants

pubmed: 39237504
doi: 10.1038/s41467-024-51266-0
pii: 10.1038/s41467-024-51266-0
doi:

Substances chimiques

DNA, Bacterial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7114

Informations de copyright

© 2024. The Author(s).

Références

Meehan, C. J. et al. Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues. Nat. Rev. Microbiol. 17, 533–545 (2019).
pubmed: 31209399 doi: 10.1038/s41579-019-0214-5
Gagneux, S. Ecology and evolution of Mycobacterium tuberculosis. Nat. Rev. Microbiol. 16, 202–213 (2018).
pubmed: 29456241 doi: 10.1038/nrmicro.2018.8
Gagneux, S. et al. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312, 1944–1946 (2006).
pubmed: 16809538 doi: 10.1126/science.1124410
Miotto, P., Cabibbe, A. M., Borroni, E., Degano, M. & Cirillo, D. M. Role of disputed mutations in the rpob gene in interpretation of automated liquid MGIT culture results for rifampin susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 56, e01599–17 (2018).
pubmed: 29540456 pmcid: 5925711 doi: 10.1128/JCM.01599-17
Gehre, F. et al. Deciphering the growth behaviour of Mycobacterium africanum. PLoS Negl. Trop. Dis. 7, e2220 (2013).
pubmed: 23696911 pmcid: 3656116 doi: 10.1371/journal.pntd.0002220
Dhillon, J., Fourie, P. B. & Mitchison, D. A. Persister populations of Mycobacterium tuberculosis in sputum that grow in liquid but not on solid culture media. J. Antimicrob. Chemother. 69, 437–440 (2014).
pubmed: 24072170 doi: 10.1093/jac/dkt357
Mohamed, S., Köser, C. U., Salfinger, M., Sougakoff, W. & Heysell, S. K. Targeted next-generation sequencing: a Swiss army knife for mycobacterial diagnostics? Eur. Respir. J. 57, 2002132 (2021).
doi: 10.1183/13993003.04077-2020
Goig, G. A., Blanco, S., Garcia-Basteiro, A. L. & Comas, I. Contaminant DNA in bacterial sequencing experiments is a major source of false genetic variability. BMC Biol. 18, 1–15 (2020).
doi: 10.1186/s12915-020-0748-z
Eshetie, S. & van Soolingen, D. The respiratory microbiota: new insights into pulmonary tuberculosis. BMC Infect. Dis. 19, 92 (2019).
pubmed: 30683056 pmcid: 6347808 doi: 10.1186/s12879-019-3712-1
Goig, G. A. et al. Whole-genome sequencing of Mycobacterium tuberculosis directly from clinical samples for high-resolution genomic epidemiology and drug resistance surveillance: an observational study. Lancet Microbe 1, e175–e183 (2020).
pubmed: 35544271 doi: 10.1016/S2666-5247(20)30060-4
Votintseva, A. A. et al. Same-day diagnostic and surveillance data for tuberculosis via whole-genome sequencing of direct respiratory samples. J. Clin. Microbiol. 55, 1285–1298 (2017).
pubmed: 28275074 pmcid: 5405248 doi: 10.1128/JCM.02483-16
Brown, A. C. et al. Rapid whole-genome sequencing of Mycobacterium tuberculosis isolates directly from clinical samples. J. Clin. Microbiol. 53, 2230–2237 (2015).
pubmed: 25972414 pmcid: 4473240 doi: 10.1128/JCM.00486-15
Shockey, A. C., Dabney, J. & Pepperell, C. S. Effects of host, sample, and in vitro culture on genomic diversity of pathogenic mycobacteria. Front. Genet. 10, 477 (2019).
pubmed: 31214242 pmcid: 6558051 doi: 10.3389/fgene.2019.00477
Doyle, R. M. et al. Direct whole-genome sequencing of sputum accurately identifies drug-resistant mycobacterium tuberculosis faster than MGIT culture sequencing. J. Clin. Microbiol. 56, e00666–18 (2018).
pubmed: 29848567 pmcid: 6062781 doi: 10.1128/JCM.00666-18
Nilgiriwala, K. et al. Genomic sequencing from sputum for tuberculosis disease diagnosis, lineage determination, and drug susceptibility. Prediction. J. Clin. Microbiol. 61, e0157822 (2023).
pubmed: 36815861 doi: 10.1128/jcm.01578-22
Nimmo, C. et al. Whole genome sequencing Mycobacterium tuberculosis directly from sputum identifies more genetic diversity than sequencing from culture. BMC Genomics 20, 389 (2019).
pubmed: 31109296 pmcid: 6528373 doi: 10.1186/s12864-019-5782-2
Goossens, S. N. et al. Detection of minor variants in Mycobacterium tuberculosis whole genome sequencing data. Brief. Bioinform. 23, bbab541 (2022).
pubmed: 34962257 doi: 10.1093/bib/bbab541
Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589–595 (2010).
pubmed: 20080505 pmcid: 2828108 doi: 10.1093/bioinformatics/btp698
Structural variants and the SAM format—the long (reads) and short (reads) of it. https://cmdcolin.github.io/posts/2022-02-06-sv-sam .
Coll, F. et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat. Commun. 5, 1–5 (2014).
doi: 10.1038/ncomms5812
Mann, B. C., Jacobson, K. R., Ghebrekristos, Y., Warren, R. M. & Farhat, M. R. Assessment and validation of enrichment and target capture approaches to improve Mycobacterium tuberculosis WGS direct patient samples. J. Clin. Microbiol. 61, e0038223 (2023).
pubmed: 37728909 doi: 10.1128/jcm.00382-23
Use of targeted next-generation sequencing to detect drug-resistant tuberculosis. https://www.who.int/publications/i/item/9789240076372 .
Moreno-Molina, M. et al. Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections. Nat. Commun. 12, 2716 (2021).
pubmed: 33976135 pmcid: 8113332 doi: 10.1038/s41467-021-22705-z
Lieberman, T. D. et al. Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosis. Nat. Med. 22, 1470–1474 (2016).
pubmed: 27798613 pmcid: 5508070 doi: 10.1038/nm.4205
Van Deun, A. et al. Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown. Eur. Respir. J. 58, 2100783 (2021).
pubmed: 33926970 doi: 10.1183/13993003.00783-2021
Pandey, P. et al. Mycobacterium tuberculosis polyclonal infections through treatment and recurrence. PLoS ONE 15, e0237345 (2020).
pubmed: 32813724 pmcid: 7437862 doi: 10.1371/journal.pone.0237345
Mukamolova, G. V., Turapov, O., Malkin, J., Woltmann, G. & Barer, M. R. Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in Sputum. Am. J. Respir. Crit. Care Med. 181, 174–180 (2010).
pubmed: 19875686 doi: 10.1164/rccm.200905-0661OC
Chengalroyen, M. D. et al. Detection and quantification of differentially culturable tubercle bacteria in sputum from patients with tuberculosis. Am. J. Respir. Crit. Care Med. 194, 1532–1540 (2016).
pubmed: 27387272 pmcid: 5215032 doi: 10.1164/rccm.201604-0769OC
Kubica, G. P., Dye, W. E., Cohn, M. L. & Middlebrook, G. Sputum digestion and decontamination with N-acetyl-L-cysteine—sodium hydroxide for culture of mycobacteria. Am. Rev. Respir. Dis. 87, 775–779 (1963).
pubmed: 13927224
Tripathi, K. et al. Modified Petroff’s method: an excellent simplified decontamination technique in comparison with Petroff’s method. Int J. Recent Trends Sci. Technol. 10, 461–464 (2014).
Somerville, W., Thibert, L., Schwartzman, K. & Behr, M. A. Extraction of Mycobacterium tuberculosis DNA: a question of containment. J. Clin. Microbiol. 43, 2996–2997 (2005).
pubmed: 15956443 pmcid: 1151963 doi: 10.1128/JCM.43.6.2996-2997.2005
Goig, G. A. et al. Towards next-generation diagnostics for tuberculosis: identification of novel molecular targets by large-scale comparative genomics. Bioinformatics 36, 985–989 (2020).
pubmed: 31580405 doi: 10.1093/bioinformatics/btz729
Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884–i890 (2018).
pubmed: 30423086 pmcid: 6129281 doi: 10.1093/bioinformatics/bty560
Wood, D. E. & Salzberg, S. L. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol. 15, R46 (2014).
pubmed: 24580807 pmcid: 4053813 doi: 10.1186/gb-2014-15-3-r46
Comas, I. et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat. Genet. 42, 498–503 (2010).
pubmed: 20495566 pmcid: 2883744 doi: 10.1038/ng.590
Koboldt, D. C. et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25, 2283–2285 (2009).
pubmed: 19542151 pmcid: 2734323 doi: 10.1093/bioinformatics/btp373
Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).
pubmed: 33590861 pmcid: 7931819 doi: 10.1093/gigascience/giab008
McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).
pubmed: 20644199 pmcid: 2928508 doi: 10.1101/gr.107524.110
Marin, M. et al. Benchmarking the empirical accuracy of short-read sequencing across the M. tuberculosis genome. Bioinformatics 38, 1781–1787 (2022).
pubmed: 35020793 pmcid: 8963317 doi: 10.1093/bioinformatics/btac023
McHugh, M. L. Interrater reliability: the kappa statistic. Biochem. Med. 22, 276–282 (2012).
doi: 10.11613/BM.2012.031
Walker, T. M. et al. The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis. Lancet Microbe 3, e265–e273 (2022).
pubmed: 35373160 pmcid: 7612554 doi: 10.1016/S2666-5247(21)00301-3
Stucki, D. et al. Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages. Nat. Genet. 48, 1535–1543 (2016).
pubmed: 27798628 pmcid: 5238942 doi: 10.1038/ng.3704
Paradis, E. & Schliep, K. ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R. Bioinformatics 35, 526–528 (2019).
pubmed: 30016406 doi: 10.1093/bioinformatics/bty633
Kumar, S., Stecher, G., Li, M., Knyaz, C. & Tamura, K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 35, 1547–1549 (2018).
pubmed: 29722887 pmcid: 5967553 doi: 10.1093/molbev/msy096

Auteurs

Carla Mariner-Llicer (C)

Instituto de Biomedicina de Valencia, IBV, CSIC, València, Spain.

Galo A Goig (GA)

University of Basel, Basel, Switzerland.
Swiss Tropical and Public Health Institute, Allschwil, Switzerland.

Manuela Torres-Puente (M)

Instituto de Biomedicina de Valencia, IBV, CSIC, València, Spain.

Sergo Vashakidze (S)

National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
The University of Georgia, Tbilisi, Georgia.

Luis M Villamayor (LM)

FISABIO, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, València, Spain.

Belén Saavedra-Cervera (B)

ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Wellcome Sanger Institute, Hinxton, UK.

Edson Mambuque (E)

Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.

Iza Khurtsilava (I)

National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.

Zaza Avaliani (Z)

National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
European University, Tbilisi, Georgia.

Alex Rosenthal (A)

Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.

Andrei Gabrielian (A)

Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.

Marika Shurgaia (M)

National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.

Natalia Shubladze (N)

National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.

Alberto L García-Basteiro (AL)

ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
CIBERINFEC, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Barcelona, Spain.

Mariana G López (MG)

Instituto de Biomedicina de Valencia, IBV, CSIC, València, Spain. mglopez@ibv.csic.es.

Iñaki Comas (I)

Instituto de Biomedicina de Valencia, IBV, CSIC, València, Spain. icomas@ibv.csic.es.
CIBERESP, Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain. icomas@ibv.csic.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH